American Funds 2045 Target Date Retirement Fund® Class R-2E (RBHHX) цена на заеднички фонд и вести

Почетна страницаRBHHX • Заеднички фонд

American Funds 2045 Target Date Retirement Fund® Class R-2E

23,93 $

13 фев. · USD · MUTF · Оградување

American Funds 2045 Target Date Retirement Fund® Class F-1

24,27 $

FATTX0,082 %

American Funds 2045 Target Date Retirement Fund® Class C

23,82 $

CCHTX0,084 %

American Funds 2045 Target Date Retirement Fund® Class A

24,50 $

AAHTX0,082 %

American Funds 2045 Target Date Retirement Fund® Class F-3

24,56 $

FCHTX0,081 %

American Funds 2045 Target Date Retirement Fund® Class R-2

23,63 $

RBHTX0,085 %

American Funds 2045 Target Date Retirement Fund® Class R-5E

24,40 $

RHHTX0,12 %

American Funds 2045 Target Date Retirement Fund® Class F-2

24,52 $

FBHTX0,082 %

American Funds 2045 Target Date Retirement Fund® Class R-6

24,71 $

RFHTX0,12 %

American Funds 2045 Target Date Retirement Fund® Class R-4

24,45 $

RDHTX0,082 %

American Funds 2045 Target Date Retirement Fund® Class R-3

24,07 $

RCHTX0,083 %

Заеднички фонд

Прет. посл. цена

23,91 $

Поврат за тековна година до денешен датум

2,61 %

Стапка на вкупни трошоци

1,16 %

Категорија

Target Date

Morningstar оцена

Нето средства

349,11 М USD

Принос

0,28 %

Влезна провизија

Датум на создавање

29 авг. 2014 г.

Вести за пазарот

TradingView

пред 52 минути

SPX Sector AD + Iceberg TICK — Indicator by nellutla

.INX

0,050 %

Investor's Business Daily

пред 57 минути

Dow Jones Futures: How To Handle This Dangerous Market; Apple, Google, Amazon, Nvidia Hit Indexes

SPDR’s Aerospace & Defense ETF Took An Unusual Approach That Smoked The S&P 500 With 54% Run

Earnings Scorecard: 5 of 8 S&P 500 real estate companies post lower earnings (XLRE:NYSEARCA)

Raleigh News & Observer

пред 5 часа

New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)

Nasdaq

пред 4 часа

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress